Risk of and Mortality After Acute Kidney Injury Following Cancer Treatment: A Cohort Study
Cancer Medicine · 2025-02 · 14 (3)
DOI: 10.1002/cam4.70646 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Cancer Medicine, online erschienen am 10.02.2025. Verfasst von Philip Vestergaard Munch und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Epidemiology, Aarhus University Hospital, Aarhus, Denmark. Hauptthemen laut MEDLINE: Acute Kidney Injury, Neoplasms, Antineoplastic Agents. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Aarhus Universitet, Fonden til Lægevidenskabens Fremme.
Abstract (Originalsprache)
Background
Acute kidney injury (AKI) can be a severe complication in cancer patients. However, uncertainty remains regarding the risk of and prognosis after AKI following cancer treatments. We therefore aimed to examine the risk of and mortality after AKI following a wide range of specific cancer treatments, including surgical procedures, anticancer drugs, and hematopoietic stem cell transplantations (HSCTs).
Methods
We conducted a nationwide population‐based cohort study. We included adult patients receiving cancer treatment in Denmark from 2010 to 2024. We calculated the risk of AKI within 7 days after surgeries, 1 year after initiation of anticancer drugs, and 100 days after HSCTs. Furthermore, we examined the 1‐year mortality in patients with and without AKI following cancer treatment.
Results
We identified 357,870 cancer patients. The 7‐day risk of AKI after surgery ranged from 0.3% (breast cancer surgery) to 68.9% (radical nephrectomy in kidney cancer) while the 1‐year risk following anticancer drug treatment ranged from 3.5% (cyclophosphamide in breast cancer) to 79.3% (all drugs in acute lymphatic leukemia). The 100‐day AKI risk following HSCT ranged from 20.7% (multiple myeloma) to 81.8% (leukemia). For most treatments, AKI was associated with a higher 1‐year hazard ratio and risk of death, with exceptions including radical nephrectomy in kidney cancer.
Conclusion
In conclusion, several cancer treatments were associated with a high risk of AKI, and AKI was associated with increased mortality in most treatments. These findings highlight the prognostic value of assessing kidney function following specific cancer treatments in clinical practice.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Clinical Epidemiology, Aarhus University Hospital, Aarhus, Denmark.
- Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.
- Department of Renal Medicine, Aarhus University Hospital, Aarhus, Denmark.
- Department of Biomedicine, Aarhus University, Aarhus, Denmark.
- Department of Oncology, Aarhus University Hospital, Aarhus, Denmark.
ORCID-Profile: Philip Vestergaard Munch, Mette Nørgaard, Simon Kok Jensen, Henrik Birn, Henrik Schmidt, Christian Fynbo Christiansen
Förderung
- Aarhus Universitet
- Fonden til Lægevidenskabens Fremme
Zitieren
APA
Munch, P. V., Nørgaard, M., Jensen, S. K., Birn, H., Schmidt, H., & Christiansen, C. F. (2025). Risk of and Mortality After Acute Kidney Injury Following Cancer Treatment: A Cohort Study. Cancer Medicine, 14(3). https://doi.org/10.1002/cam4.70646
Vancouver
Munch PV, Nørgaard M, Jensen SK, Birn H, Schmidt H, Christiansen CF. Risk of and Mortality After Acute Kidney Injury Following Cancer Treatment: A Cohort Study. Cancer Medicine. 2025;14(3). doi:10.1002/cam4.70646
BibTeX
@article{Munch2025,
author = {Munch, Philip Vestergaard and Nørgaard, Mette and Jensen, Simon Kok and Birn, Henrik and Schmidt, Henrik and Christiansen, Christian Fynbo},
title = {Risk of and Mortality After Acute Kidney Injury Following Cancer Treatment: A Cohort Study},
journal = {Cancer Medicine},
year = {2025},
volume = {14},
number = {3},
doi = {10.1002/cam4.70646}
}
EUVIMED